Tag: Cancer: Laryngeal
Certain Oral Bacteria Tied to Risk for New Head, Neck Squamous Cell Cancer
13 oral bacterial species associated with development of head, neck cancer over five years
2023 Cisplatin Shortage Tied to Use of Alternatives for Head, Neck Cancer
Alternative treatments came at significantly higher costs for both payers, patients
Salivary CD44, Total Protein ID Recurrence Risk in Head and Neck Cancer
Higher CD44 and total protein levels linked to increased hazard ratios for recurrence in multivariate adjusted analysis
Cannabis-Related Disorder Linked to Risk for Head and Neck Cancer
Risk increased for any head and neck cancer, especially oral, oropharyngeal, and laryngeal cancer
Higher Mortality, Less Improvement Seen for Rural Residents With Head, Neck Cancer
Higher age-adjusted mortality rates, slower annual improvement seen in rural versus small/medium and large metropolitan areas
Guidelines Address RT for Management of HPV-Linked Oropharyngeal Cancer
Tailored recommendations presented to maximize survival and minimize side effects
AACR: Novel Personalized Vaccine Feasible for Head and Neck Cancer
Vaccination found to be safe and induces polyclonal immune responses against vaccine targets
Decrease in Head and Neck Cancer Incidence Seen During Pandemic
Localized cancer incidence decreased the most among men, Hispanic patients, individuals with larynx cancer
Community Cancer Centers Treating More HPV-Related Head, Neck Cancer
More patients being treated nonsurgically tied to worse survival
AI Pipeline Can Accurately Measure Sarcopenia in Head and Neck Cancer
Skeletal muscle index-derived sarcopenia associated with worse overall survival, longer feeding tube duration
